[Form 4] Helius Medical Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Texas Roadhouse, Inc. (TXRH) filed a Form 4 on 07/03/2025 disclosing an equity award to Interim Chief Financial Officer Keith Humpich. On 07/02/2025, Humpich received 2,114 Restricted Stock Units (RSUs) under the company’s 2021 Long-Term Incentive Plan. Each RSU represents the conditional right to receive one share of common stock on 07/02/2026, contingent upon continued service. The filing shows no sales or purchases of common stock; it merely reports the grant and the officer’s post-grant ownership of 20,059 shares held directly.

The RSU award aligns executive compensation with shareholder value but is modest relative to Texas Roadhouse’s overall share count and market capitalization. The transaction is routine, indicates no change in strategic outlook, and does not materially affect the company’s capitalization or insider ownership structure.

Insights

Securities Analyst

TL;DR: Routine RSU grant to interim CFO; neutral impact on TXRH valuation and insider sentiment.

The Form 4 reports a standard compensation grant—2,114 RSUs—worth roughly mid-six figures at recent prices. No shares were sold, so there is no negative selling signal. While the additional equity slightly increases insider alignment, the size is immaterial to share count and does not signal incremental confidence beyond normal compensation practices. Therefore, the filing is informational rather than market-moving.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walter Blane

(Last) (First) (Middle)

C/O HELIUS MEDICAL TECHNOLOGIES, INC.

642 NEWTOWN YARDLEY ROAD, SUITE 100

(Street)

NEWTOWN PA 18940

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HELIUS MEDICAL TECHNOLOGIES, INC. [ HSDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.76	07/02/2025		A		2,600		(1)	07/01/2035	Class A Common Stock	2,600	$0	2,600	D

Explanation of Responses:

1. Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of four (4) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period.

	/s/ Stephanie Swan, by Power of Attorney	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Texas Roadhouse (TXRH) file on July 3, 2025?

A Form 4 reporting insider equity activity for Interim CFO Keith Humpich.

How many Restricted Stock Units were granted to Interim CFO Keith Humpich?

He received 2,114 RSUs on July 2, 2025.

When do the granted RSUs to Keith Humpich vest?

The RSUs vest on July 2, 2026, with share delivery on that date.

How many Texas Roadhouse shares does Keith Humpich own after the transaction?

He directly owns 20,059 common shares following the reported grant.

Does the Form 4 show any insider selling of TXRH stock?

No. The filing reports an equity grant only; there were no sales or disposals.